Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762751 | PMC |
| http://dx.doi.org/10.5045/br.2017.52.4.334 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Low-dose Systemic Tissue-type-plasminogen-activator Compared to Conventional Anti-coagulation for the Treatment of Intermediate-high Risk Pulmonary Embolism.
Cardiovasc Hematol Disord Drug Targets
January 2025
Division of Pulmonary and Critical Care Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA.
Background: Pulmonary embolism (PE) is a frequent cause of death. Acute PE may be treated either with full anticoagulation (AC) alone or thrombolytic therapy with systemic tissue-- type-plasminogen-activator (tPA) based on risk assessment. Currently, AC is the standard of care for most patients with intermediate-high-risk PE, with low-dose tPA emerging as an effective alternative.
View Article and Find Full Text PDFDiagnostic performance of optical spectral transmission compared to magnetic resonance imaging in patients with inflammatory arthritis.
Arthritis Res Ther
January 2025
Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Herne, Germany.
Background: Optical spectral transmission (OST) is a modern diagnostic method capable of quantifying inflammation in the finger and wrist joints of arthritis patients by assessing the blood-specific absorption of light transmitted through a tissue. The diagnostic performance of this modality has not been adequately examined and data regarding OST associations with magnetic resonance imaging (MRI) are limited. Aim of this study was therefore to investigate the performance of OST in assessing joint inflammation as compared to MRI in patients with inflammatory arthritis (IA).
View Article and Find Full Text PDFA Comparison of Patient and Provider Perspectives on an Electronic Health Record-Based Discharge Communication Tool: Survey Study.
JMIR Aging
January 2025
JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China (Hong Kong).
Background: Hospital discharge for older adult patients carries risks. Effective patient-provider communication is crucial for postacute care. Technology-based communication tools are promising in improving patient experience and outcomes.
View Article and Find Full Text PDFAssessing sub-Saharan Africa's GHG emissions from croplands: environmental impacts and sustainable mitigation strategies.
Environ Monit Assess
January 2025
Department of Environmental Management, Institute of Environmental Engineering, RUDN University, Miklukho-Maklaya Street, 117198, Moscow, Russia.
Globally, agricultural lands are among the top emitters of greenhouse gases (GHGs), responsible for over 20% of total greenhouse gas (GHG) emissions. Climatic conditions, an acute challenge in sub-Saharan Africa (SSA), where access to mitigation technologies remains limited, have heavily influenced these lands. This study explores GHG contributions from crop production and their devastating and deteriorating impacts on the economy and environment and proposes a sustainable solution.
View Article and Find Full Text PDFNormal tissue complication probability model predicting taste impairment in head and neck cancer patients: Evaluating the taste bud bearing tongue mucosa as a predictor.
Radiother Oncol
January 2025
Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Electronic address:
Background/purpose: Taste impairment is a common yet complex toxicity of head and neck cancer (HNC) radiotherapy treatment that may affect quality of life of survivors. This study aimed to predict acute and late taste impairment using taste bud bearing tongue mucosa as a new taste-specific organ-at-risk compared to full oral cavity as identified in previous studies.
Materials/methods: Included HNC patients were treated with curative radiotherapy between 2007 and 2022.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!